Lilly cuts insulin prices by 70%, caps patient insulin costs
By PRNewswire Eli Lilly and Company on March 1 announced price reductions of 70% for its most commonly prescribed insulins and an expansion of its Insulin Value Program that caps patient out-of-pocket costs at $35 or less per month. Lilly is taking these actions to make it easier to access Lilly insulin and help Americans…